Florida to Get $870M From CVS, Drug Companies in Opioid Case

Florida to Get $870M From CVS, Drug Companies in Opioid Case

Carolyn Crist

April 01, 2022

0

Florida will receive more than $870 million from CVS Health and three drug companies as part of the settlement of a major opioid case, according to The Associated Press.

The money must be spent on tackling the opioid crisis in the state, including prevention efforts, treatment, or recovery services. The funds will be divided between the state and Florida's cities and counties, which have been battling an overwhelming number of opioid overdoses and massive illicit drug use due to the "pill mill" epidemic, the AP reported.

"The opioid epidemic is wreaking havoc on Florida families," Ashley Moody, Florida's attorney general, said in a statement.

"I have worked tirelessly to hold accountable those companies who helped start this crisis," she said. "The monies…will help further our efforts to remediate the harm and suffering of Floridians."

CVS Health Corp. and CVS Pharmacy Inc. will pay $484 million. Teva Pharmaceuticals Industries Ltd. will pay $195 million, Allergan PLC will pay $134 million, and Endo Health Solutions will pay $65 million.

In addition, Teva will provide $84 million worth of its naloxone nasal spray, a medication that temporarily reverses the effects of opioids when an overdose occurs.

After California, Florida reports the second-highest number of overdose deaths per year, according to the

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....